EFFECTS OF NEW 1st, 2nd, 3rd TRIAZOLE PRODUCTS ON BIOCHEMICAL INDICATORS OF BLOOD PLASMA AND ACTIVITY OF LIVER ANTIOXIDANT IN DIABETES CAUSED BY ALLOXAN
Main Article Content
Abstract
This study established the effect of new derivatives of TF-25, TS-27, and ISO-31-triazoles on the activity of triglycerides, total cholesterol, the hormone insulin and the antioxidant enzyme superoxide dismutase (SOD), catalase in rat liver homogenate in diabetes mellitus caused by alloxan, and also on the amount of MDА, the product of lipid peroxidation.
Studies were performed on male, white, breedless rats weighing 190–210 g. A solution of alloxan monohydrate (150 mg/kg) was used to create a diabetes model in rats. The experimental animals were divided into five groups. New TF-25 (40 mg/kg), TS-27 (15 mg/kg) and ISO-31 (25 mg/kg) derivatives of 1,2,3-triazoles were administered to alloxan diabetes mice for 10 days on a “per os” method. TF-25, TS-27, and ISO-31 triazole derivatives reversed body weight loss in rats in alloxan diabetes. New TF-25, TS-27, and ISO-31 derivatives of 1,2,3-triazole reduced the increase in plasma triglycerides and total cholesterol in diabetics. It was found that by increasing the amount of insulin, its secretion was restored. The new TF-25, TS-27, and ISO-31 derivatives of 1,2,3-triazole restored the activity of the enzymes SOD and catalase, which had decreased antioxidant activity in the liver homogenate of rats in alloxan diabetes. In diabetes mellitus, the LPO product in liver homogenate inhibited the intensity of MDA formation, the new TF-25, TS-27 and ISO-31 derivatives of 1,2,3-triazole.
Downloads
Metrics
Article Details
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
